Mental health, dermatology-related quality of life, and the role of probiotics

Photo by Ketut Subiyanto via Pexels

Mental health symptoms and skin disease appear to be connected for many adults, especially for women, according to a new Brazilian study published in the Journal of Dermatologic Science and Cosmetic Technology. 

The researchers investigated the skin–brain axis and looked at the presumed benefits of probiotics. Their findings suggest that common psychiatric symptoms, rather than diet-related microbial factors, may be the primary drivers of anxiety in this population.

They analyzed 305 adults in Brazil, assessing anxiety, depression, stress, dermatology-related quality of life (DLQI), and self-reported probiotic intake. Women consistently reported higher symptom scores across all three mental health domains: mean anxiety scores were 13.0 compared with 7.7 in men, mean depression scores were 15.9 versus 10.6, and mean stress scores were 20.0 versus 13.4, all with p values less than 0.001.

“Nearly half of participants reported dermatological disorders, and over half were at risk for at least one mental health condition,” said corresponding author Débora Fernandes Pinheiro, PhD, in a press release. “Strong positive correlations were found among anxiety, depression, and stress, while DLQI showed weak but significant correlations with these outcomes.”

Dr. Pinheiro is a Professor at the University Alto Vale do Rio do Peixe in Caçador, Brazil.

The investigators report that mental health measures were tightly interlinked: correlation coefficients between anxiety and depression, anxiety and stress, and depression and stress ranged from 0.77 to 0.83, all statistically significant at p less than 0.001. In contrast, dermatology-related quality of life showed only weak, albeit significant, associations with these psychiatric scores, underscoring that even modest skin disease burden may coincide with substantial psychological distress. More than one-half of participants were classified as at risk for at least one mental health condition, highlighting what the authors describe as a substantial—and disproportionately female—psychosocial load associated with skin symptoms.

Probiotics, long promoted for gut–brain and gut–skin benefits, did not show meaningful associations with anxiety, depression, or stress in this cohort. Reported intake was low, and the authors caution that any null findings may reflect insufficient exposure rather than the absence of a biological effect. In multivariable models, stress and depression emerged as independent predictors of anxiety, together accounting for 66% of its variance (R²=0.66, p<0.01), suggesting that targeting these domains may be critical in clinical management.

“Our findings highlight the bidirectional nature of the skin–brain axis and the disproportionate psychological and dermatological burden on women,” Dr. Pinheiro said.

“While probiotics hold theoretical promise, current evidence from this population does not support direct associations. Further longitudinal studies incorporating culturally relevant dietary patterns are needed to clarify these complex interactions.”

For clinicians, the authors say, routine screening for anxiety, depression, and stress in patients with dermatologic complaints—particularly women—may be at least as important as advising on emerging microbiome-directed therapies.